Transgene S.A.
TRGNF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $17 | $17 | $15 | $16 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $1 | $1 | $2 | $1 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $4 | $3 | $2 | $1 |
| Total Curr. Assets | $22 | $21 | $19 | $18 |
| Property Plant & Equip (Net) | $14 | $14 | $14 | $12 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $1 | $0 | $1 | $1 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $4 | $7 | $17 | $13 |
| Total NC Assets | $19 | $22 | $32 | $27 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $41 | $42 | $51 | $45 |
| Liabilities | – | – | – | – |
| Payables | $7 | $10 | $7 | $5 |
| Short-Term Debt | $29 | $0 | $0 | $1 |
| Tax Payable | $0 | $0 | $3 | $4 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $4 | $4 | $2 | $1 |
| Total Curr. Liab. | $40 | $14 | $12 | $10 |
| LT Debt | $2 | $10 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $33 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $3 | $3 | $3 | $20 |
| Total NC Liab. | $4 | $13 | $36 | $20 |
| Other Liabilities | $0 | $0 | $3 | $0 |
| Cap. Leases | $0 | $0 | $0 | $1 |
| Total Liabilities | $45 | $27 | $51 | $30 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $40 | $66 | $51 | $50 |
| Retained Earnings | -$58 | -$140 | -$122 | -$106 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $15 | $89 | $71 | $71 |
| Total Equity | -$4 | $15 | -$1 | $16 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $41 | $42 | $51 | $45 |
| Net Debt | $14 | -$6 | -$15 | -$14 |